ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04110	Cell cycle	32/330	145/7206	4.07538072263e-14
ko03040	Spliceosome	31/330	145/7206	2.60748545492e-13
ko04111	Cell cycle - yeast	23/330	90/7206	7.10768785725e-12
ko05217	Basal cell carcinoma	16/330	68/7206	4.36501041403e-08
ko03410	Base excision repair	11/330	38/7206	6.2262248132e-07
ko04080	Neuroactive ligand-receptor interaction	2/330	423/7206	8.20491308707e-07
ko04340	Hedgehog signaling pathway	13/330	58/7206	1.49920299993e-06
ko04113	Meiosis - yeast	14/330	70/7206	2.54446082263e-06
ko03030	DNA replication	10/330	38/7206	5.31632591789e-06
ko03015	mRNA surveillance pathway	15/330	93/7206	1.79486640459e-05
ko05224	Breast cancer	21/330	174/7206	4.11577734416e-05
ko04020	Calcium signaling pathway	1/330	265/7206	7.23126168766e-05
ko05166	HTLV-I infection	29/330	292/7206	7.49445480308e-05
ko04550	Signaling pathways regulating pluripotency of stem cells	19/330	165/7206	0.00017963903606
ko04330	Notch signaling pathway	10/330	62/7206	0.000454054177895
ko04144	Endocytosis	4/330	342/7206	0.000758354914218
ko04310	Wnt signaling pathway	19/330	181/7206	0.000774260031035
ko04060	Cytokine-cytokine receptor interaction	1/330	191/7206	0.00232858730992
ko04612	Antigen processing and presentation	10/330	77/7206	0.00252270677255
ko04218	Cellular senescence	17/330	177/7206	0.00319162929413
ko05205	Proteoglycans in cancer	23/330	271/7206	0.00423830451989
ko05200	Pathways in cancer	36/330	492/7206	0.00487419072902
ko04910	Insulin signaling pathway	1/330	172/7206	0.00489027307717
ko04120	Ubiquitin mediated proteolysis	14/330	138/7206	0.0056047389997
ko05202	Transcriptional misregulation in cancer	17/330	188/7206	0.00685471027411
ko05418	Fluid shear stress and atherosclerosis	16/330	173/7206	0.00821601600396
ko04072	Phospholipase D signaling pathway	2/330	197/7206	0.00882321067589
ko04950	Maturity onset diabetes of the young	5/330	29/7206	0.0093661323347
ko05012	Parkinson's disease	1/330	155/7206	0.0103266177301
ko04725	Cholinergic synapse	1/330	160/7206	0.0108950631644
ko04360	Axon guidance	19/330	233/7206	0.0152275539225
ko03420	Nucleotide excision repair	6/330	46/7206	0.0175868978058
ko04022	cGMP-PKG signaling pathway	3/330	216/7206	0.0191211293378
ko04390	Hippo signaling pathway	16/330	188/7206	0.0191529381322
ko05222	Small cell lung cancer	9/330	89/7206	0.0201156849226
ko04931	Insulin resistance	1/330	137/7206	0.0215458470626
ko04726	Serotonergic synapse	1/330	137/7206	0.0215458470626
ko05130	Pathogenic Escherichia coli infection	8/330	77/7206	0.0239250208396
ko04723	Retrograde endocannabinoid signaling	2/330	175/7206	0.025522819625
ko05206	MicroRNAs in cancer	15/330	177/7206	0.0261014873754
ko04921	Oxytocin signaling pathway	3/330	209/7206	0.026805291012
ko03460	Fanconi anemia pathway	6/330	51/7206	0.0279801643558
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	4/330	26/7206	0.0290909940609
ko01522	Endocrine resistance	11/330	124/7206	0.0291662341722
ko04922	Glucagon signaling pathway	1/330	128/7206	0.0310338999472
ko04915	Estrogen signaling pathway	1/330	131/7206	0.0316459726056
ko05231	Choline metabolism in cancer	1/330	134/7206	0.0328236326547
ko00240	Pyrimidine metabolism	10/330	110/7206	0.034272466175
ko04911	Insulin secretion	1/330	117/7206	0.0444965724537
ko04211	Longevity regulating pathway	1/330	123/7206	0.0458487758579
ko00514	Other types of O-glycan biosynthesis	4/330	30/7206	0.046273809053
ko03022	Basal transcription factors	5/330	44/7206	0.0492128622